Sign in
4/A

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000053

Chief Accounting Officer sold 190 shares at $2.03 ($385)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Simoneit Diona Chief Accounting Officer 2022-11-15 Sale −190 $2.03 $385 29,318 D: show line 1 in the form
Open-market sales · 190 sh · avg $2.03 · $385
Loading xslF345X03/edgardoc.xml…